Unichem Laboratories Ltd


BSE: 506690 | NSE: UNICHEMLAB | ISIN: INE351A01035 
Market Cap: [Rs.Cr.] 1,508 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

11-May-13 
Unichem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 11, 2013, inter-alia, to consider and take on record Audited Accounts for the year ended March 31, 2013 and to recommend Dividend on equity shares for the Financial year 2012-13, if any. Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2013, inter alia, has recommended Dividend of Rs. 4.50 (225%) per equity share of Rs. 2/- each, for the year ended March 31, 2013, subject to approval of Shareholders at ensuring Annual General Meeting. Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2013, inter alia, has considered the following: - Allotted and issued 13,750 equity shares of Rs. 2/- each pursuant to the exercise of the Stock Option Scheme - 2008 of the Company. (As per BSE Announcement Dated on 11.05.2013) 
20-Mar-13 
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 20,2013,has allotted and issued 8,312 equity shares of Rs.2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock option Scheme 2004 and Employee Stock option Scheme 2008 of the Company. Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 20, 2013, allotted and issued 8,312 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock option Scheme 2004 and Employee Stock option Scheme 2008 of the Company. 
15-Feb-13 
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 15, 2013, has discussed and decided on the following; 1. Board approved the sale of Company's new formulation manufacturing unit located at Industrial Area, Special Economic Zone, Phase 2, of Tehsil Dhar of the Dhar District, Madhya Pradesh, Republic of India, the site comprising an area admeasuring 1,17,301 square meters along with all assets comprising the formulation unit, on a slump sale basis to M/s. Mylan Laboratories Limited ('Mylan')for a total consideration of Rs. 160.50 crores ('Proposed Sale') subject to execution of a definitive agreement(s) between the Company and Mylan, reflecting detail terms and condition for the proposed sale and subject to approval of shareholders through a postal ballot and on receipt of requisite/regulatory approvals. 2. Board approved the Notice and Explanatory Statement for conducting postal ballot for seeking approval of the shareholders for the aforesaid Proposed Sale pursuant to section 293(1)(a) and 192A of the Companies Act 1956. 3. Board approved calendar of events for postal ballot. 4. Board appointed Mrs. Ragini Chokshi, Practicing Company Secretary, Mumbai as scrutinizer of the postal ballot process. 
18-Jan-13 
Quarterly Results 
20-Oct-12 
Quarterly Results 

AGM

19-Jul-13
AGM : 19.07.2013 
27-Sep-12
Unichem Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 17, 2012 to September 21, 2012 (both days inclusive) for the purpose of Payment of Dividend & 49th Annual General Meeting (AGM) of the Company to be held on September 27, 2012. Unichem Laboratories Ltd has informed BSE that the 49th Annual General Meeting (AGM) of the Company will be held on September 27, 2012. (As per BSE Announcement Dated on 13.09.2012) Unichem Laboratories Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on September 27, 2012. (As per BSE Announcement Dated on 28.09.2012)  
28-Jul-11
AGM 28/07/2011 Unichem Laboratories Limited has informed the Exchange that the Annual General Meeting of the Company will be held on July 28, 2011. (As Per NSE Bulletin Dated on 14/07/2011) Unichem Laboratories Ltd has informed BSE that the members at the 48th Annual General Meeting (AGM) of the Company held on July 28, 2011, inter alia, have considered and approved the following: 1. Adoption of audited financial statements for the year ended March 31, 2011. 2. Confirmation of 1st Interim Dividend of Rs. 1.20/- per equity share of Rs. 2/-each already paid for the year ended March 31, 2011. 3. Declared Final Dividend of Rs. 2.80/- per equity share of Rs. 2/- each for the year ended March 31, 2011. 4. Re-appointment of Mr. Prafull Anubhai as Director liable to retire by rotation. 5. Re-appointment of Mr. Ramdas Gandhi as Director liable to retire by rotation. 6. Re-appointment of M/s. B. D. Jokhakar & Co. to hold office as Statutory Auditors from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting at remuneration to be fixed by the Board of Directors. 7. Appointment u/s 314(1B) of Companies Act, 1956. (As Per BSE Annoncement Website Dated on 29/07/2011) Unichem Laboratories Ltd has submitted to BSE a copy of minutes of 48th Annual General Meeting held on July 28, 2011. (As Per BSE Announcement Dated on 23.09.2011) 
16-Sep-10
AGM 16/09/2010 Unichem Laboratories Ltd has informed BSE that the members at the 47th Annual General Meeting (AGM) of the Company held on September 16, 2010, inter alia, have considered and approved the following: 1. Adoption of audited financial statements for the year ended March 31, 2010. 2. Confirmation of Interim Dividend of Rs. 10/- per equity share of Rs. 5/- each already paid for the year ended March 31, 2010 as Final Dividend 3. Re-appointment of Mr. Prafull D. Sheth as Director liable to retire by rotation 4. Re-appointment of Mr. Anand Mahajan as Director liable to retire by rotation 5. Re-appointment of M/s. B D Jokhakar & Co. as Statutory Auditors for the financial year 2010-11. 6. Sub-division of face value of equity shares of Rs. 5 /- to Rs. 2/-. 7. Alteration of Memorandum of Association to reflect the said sub-division 8. Alteration of Articles of Association to reflect the said sub-division. 9. Insertion of New Object in the Memorandum of Association subject to passing of this resolution through postal ballot. (As Per BSE Announcement Website dated on 17.09.2010) Unichem Laboratories Ltd has submitted to BSE a copy of the proceedings of the 47th Annual General Meeting (AGM) of the Company held on September 16, 2010. (As Per BSE Announcement Website dated on 22.11.2010) 
22-Jul-09
AGM 22/07/2009 Unichem Laboratories Ltd has informed BSE that the members at the 46th Annual General Meeting (AGM) of the Company held on July 22, 2009, inter alia, have considered and approved the following: 1. Adoption of audited financial statements for the year ended March 31, 2009. 2. Confirmation of Interim Dividend of Rs 3/- per equity share of Rs 5/- each already paid for the year ended March 31, 2009. 3. Declaration of Final Dividend of Rs 5/- per equity share of Rs 5/- each for the year ended March 31, 2009. 4. Re-appointment of Mr. Ramdas Gandhi & Mr. Nasser Munjee as Directors liable to retire by rotation. 5. Re-appointment of M/s. B D Jokhakar & Co. as Statutory Auditors for the financial year 2009-10. 6. Appointment of Ms. Supriya Mody u/s 314(1B). (As Per BSE Announcement Website dated on 23.07.2009) Unichem Laboratories Ltd has submitted to BSE a copy of the proceedings of the Annual General Meeting (AGM) of the Company held on July 22, 2009. (As Per BSE Announcement Website dated on 22.10.2009) 

EGM

03-Nov-11
Unichem Laboratories Ltd has submitted to BSE a copy of Court Convened meeting of the Equity Shareholders to be held on November 03, 2011. 
04-Feb-06
has considered and approved the following: 1. Preferential allotment of 1,875,000 numbers of Equity Shares to New Vernon Pvt Equity Ltd (formerly New Vernon Bharat Ltd) at a premium of Rs 295/- per equity share of Rs 5/- each. 2. Increasing the limit of investment by Foreign Institutional Investors to 49% of the issued and paid up capital of the Company. 3. Convene an Extra-Ordinary General Meeting of the Shareholders of the Company on February 04, 2006 to consider the above two proposals. EGM 04/02/2006 To consider the following: 1. Preferential allotment of 1,875,000 numbers of Equity Shares of Rs 5/- each to New Vernon Pvt Equity Ltd (formerly New Vernon Bharat Ltd), at a price of Rs 300/- each (at a premium of Rs 295/- per equity share of Rs 5/- each). 2. Increasing the limit of investment by Foreign Institutional Investors to 49% of the issued and paid up capital of the Company. (As per BSE Bulletin dated on 16/01/2006) The company has informed that the Management Committee of the Board of Directors of the Company at its meeting held on February 15, 2006, has allotted and issued 700 equity shares of Rs 5/- each pursuant to the exercise of the stock options by the eligible employees / legal heiro under the Employee Stock Option Scheme - 2004 of the Company. Further the Company has informed that the Management Committee of the Board of Directors of the Company at its meeting held on February 15, 2006, has allotted 18,75,000 equity shares of Rs 5/- each to New Vernon Pvt Equity Ltd at a price of Rs 300/- per equity share (i.e. at a premium of Rs 295/- per share), in accordance with the resolution passed by the shareholders at the Extraordinary General Meeting of the Company held on February 04, 2006 and the Guidelines for Preferential Issues (as amended from time to time) under Chapter XIII of the Securities & Exchange Board of India (Disclosure and Investor Protection) Guidelines 2000. (As per BSE Bulletin dated on 15/02/2006) The Company has informed that the members at the Extraordinary General Meeting (EGM) of the Company held on February 04, 2006, inter alia, have accorded to the following: 1. Authority to the Board to offer, issue and allot, in one or more tranches, by way of preferential allotment upto 1,875,000 Equity Shares of Rs 5 each of the Company for cash, at a price of Rs 300 per Equity Share (i.e. at a premium of Rs 295 per Equity Share) to New Vernon Pvt Equity Ltd (formerly New Vernon Bharat Ltd) on such terms and conditions as may be deemed appropriate. 2. Authority to the Board to increase the limit of investment by Foreign Institutional Investors (FIIs), Non-resident Indians (NRIs) and Overseas Corporate Body (OCBs) including their sub accounts registered with SEBI, in the equity shares of the Company, either by direct purchase or acquisition from the open market under the Portfolio Investment Scheme under FEMA, from 30% to 49% of the paid-up Equity Share Capital of the Company. (As per BSE Bulletin dated on 24/02/2006) 
04-Mar-04
Unichem Laboratories Ltd has informed the Exchange that in the meeting of the BoDs of the Company held on January 30, 2004, the Board has passed the following resolutions and decided to recommend the same to the shareholders for their approval : i) that the bonus shares be issued in the ratio of 1:1 i.e. one equity share of Rs.10/- each for every one equity share of Rs.10/- each held in the Company; ii) that the face value of equity share of the company be sub-divided from Rs.10/- each to Rs.5/- each after issue of the bonus shares; iii) that the Company will introduce a Stock Option Scheme/Stock Purchase Scheme for its employees; iv) the authorized capital of the Company be increased from Rs.25,00,00,000/- to Rs.50,00,00,000/-. The Company has convened an EGM of the shareholders on March 04, 2004 to consider the above matters. The common record date for issue Bonus shares and sub-division of shares will be fixed later. The Board has also decided to set-up a 100% wholly-owned subsidiary in U.S.A.  
28-Feb-04
Unichem Laboratories Ltd has informed the Exchange that the Company has convened an EGM of the shareholders on February 28, 2004 (and not on March 04, 2004 as mentioned earlier). EGM 28/02/2004 1. Bonus Issue. 2. Sub Division of shares. 3. Stock Option Scheme / Stock Purchase Scheme for its employees. 4. Increase in Authorised capital. (As per BSE Bulletin dated on 04/02/2004) Unichem Laboratories Ltd has informed the Exchange that an EGM of the members of the Company will be held on February 28, 2004, to transact the following business : i) The consent of the Company be and is hereby accorded to sub-divide each of the equity share of the nominal value of Rs.10/- each in the capital of the Company, into 2 equity shares of Rs.5/- each; ii) That the bonus shares be issued in the ratio of 1:1 i.e. one equity share of Rs.5/- each for every one equity share of Rs.5/- each held in the Company; iii) To incorporate an Employee Stock Option Plan (ESOP) and Employee Stock Option Scheme(s); iv) The authorized capital of the Company be increased from Rs.25,00,00,000/- to Rs.50,00,00,000/-; v) Alteration of the Memorandum and Articles of Association of the company. (As per NSE Bulletin dated on 06/02/2004) Outcome of EGM Unichem Laboratories Ltd has informed the Exchange that at the EGM of the company held on February 28, 2004 the members have approved the following: 1) Sub-division of nominal value of equity share from Rs.10/- each into 2 equity shares of Rs.5/- each. 2) Issue of Bonus equity shares in the ratio of 1:1 i.e. 1 (one) equity share of Rs.5/- each for every 1(one) equity share of Rs.5/- each held in the company after sub-division of shares. The BOD in their meeting held on February 28, 2004 have fixed the record date on March 24, 2004 for the purpose of sub-division of shares and issue of Bonus shares. (As per BSE Bulletin Date 01/03/2004) The company has informed that at the Extra Ordinary General Meeting of the Company held on February 28, 2004 theshareholders have approved the increase in the authorised capital of the Company from Rs. 25 crores to Rs. 50 crores. (As per BSE Bulletin dated on 29/03/2004)_  

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 99,536.69 192.62 12.78 27.45 26.1 27.0 0.01
Dr Reddy's Labs 35,691.50 28.20 4.69 18.79 14.3 16.6 0.25
Cipla 30,498.16 20.24 3.44 14.11 15.9 19.8 0.03
Cadila Health. 16,246.12 34.82 5.64 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,472.45 40.08 6.13 23.94 12.7 11.7 0.39
Ranbaxy Labs. 14,984.09 0.00 7.80 72.87 0.0 0.0 2.38
Wockhardt 11,962.85 32.47 14.62 12.82 237.0 30.3 2.09
Piramal Enterp. 9,614.49 0.00 0.91 23.66 0.8 2.1 0.07
Ipca Labs. 8,769.01 26.46 5.59 10.09 24.2 23.7 0.49
Torrent Pharma. 7,166.47 12.43 4.34 11.66 29.6 25.5 0.48
Biocon 5,512.00 19.22 2.50 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,279.46 10.65 1.80 22.89 10.7 8.8 1.01
Strides Arcolab 5,002.13 34.10 3.65 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,739.85 17.41 5.96 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Prakash A Mody , Chairman & Managing Director 

Prafull Anubhai , Director 

Ramdas M Gandhi , Director 

Nasser Munjee , Director 


Company Head Office / Quarters:
Unichem Bhavan Prabhat Estate,
Off S V Road Jogeshwari (West),
Mumbai,
Maharashtra-400102
Phone : 91-22-66888333
Fax : 91-22-26794089/26784391
E-mail : shares@unichemindia.com
Web : http://www.unichemlabs.com
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list ANZ Job Advertisements (MoM)
list EIA Natural Gas Storage Change
Results
list Havells India | Union Bank (I) | Dena Bank | Central Bank